Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 65,532 | 49,923 | 47,158 | 40,994 | 49,959 |
| Cost of Goods | 246 | 236 | 418 | 591 | 297 |
| Gross Profit | 65,286 | 49,687 | 46,740 | 40,403 | 49,662 |
| Operating Expenses | 100,254 | 99,876 | 99,335 | 85,578 | 79,541 |
| Operating Income | -34,722 | -49,957 | -52,177 | -44,584 | -29,582 |
| Interest Expense | 24,022 | 23,837 | 18,780 | 14,115 | 13,495 |
| Other Income | 741 | -123 | 55,431 | -102 | -121 |
| Pre-tax Income | -58,003 | -73,917 | -15,526 | -58,801 | -43,198 |
| Income Tax | 856 | 279 | N/A | N/A | N/A |
| Net Income Continuous | -58,859 | -74,196 | -17,779 | -58,801 | -43,198 |
| Net Income | $-58,859 | $-74,196 | $-17,779 | $-58,801 | $-43,198 |
| EPS Basic Total Ops | -0.32 | -0.40 | -0.10 | -0.33 | -0.24 |
| EPS Basic Continuous Ops | -0.32 | -0.40 | -0.09 | -0.33 | -0.24 |
| EPS Diluted Total Ops | -0.32 | -0.40 | -0.10 | -0.33 | -0.24 |
| EPS Diluted Continuous Ops | -0.32 | -0.40 | -0.09 | -0.33 | -0.24 |
| EBITDA(a) | $-34,505 | $-49,606 | $-52,043 | $-44,354 | $-29,363 |